Drug Type Monoclonal antibody |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 1 | US | 01 Aug 2021 | |
Brain Injuries, Traumatic | Phase 1 | US | 01 Aug 2021 | |
Glioblastoma | Phase 1 | US | 01 Aug 2021 | |
Psoriasis | Phase 1 | US | 01 Aug 2021 |